196 related articles for article (PubMed ID: 34529714)
1. Cost-effectiveness analysis of an intervention project engaging Traditional and Religious Leaders to improve uptake of childhood immunization in southern Nigeria.
Oyo-Ita AE; Hanlon P; Nwankwo O; Bosch-Capblanch X; Arikpo D; Esu E; Auer C; Meremikwu M
PLoS One; 2021; 16(9):e0257277. PubMed ID: 34529714
[TBL] [Abstract][Full Text] [Related]
2. Effects of engaging communities in decision-making and action through traditional and religious leaders on vaccination coverage in Cross River State, Nigeria: A cluster-randomised control trial.
Oyo-Ita A; Bosch-Capblanch X; Ross A; Oku A; Esu E; Ameh S; Oduwole O; Arikpo D; Meremikwu M
PLoS One; 2021; 16(4):e0248236. PubMed ID: 33861742
[TBL] [Abstract][Full Text] [Related]
3. The cost-effectiveness of supplementary immunization activities for measles: a stochastic model for Uganda.
Bishai D; Johns B; Nair D; Nabyonga-Orem J; Fiona-Makmot B; Simons E; Dabbagh A
J Infect Dis; 2011 Jul; 204 Suppl 1(Suppl 1):S107-15. PubMed ID: 21666151
[TBL] [Abstract][Full Text] [Related]
4. Assessing the cost-effectiveness of different measles vaccination strategies for children in the Democratic Republic of Congo.
Doshi RH; Eckhoff P; Cheng A; Hoff NA; Mukadi P; Shidi C; Gerber S; Wemakoy EO; Muyembe-Tafum JJ; Kominski GF; Rimoin AW
Vaccine; 2017 Oct; 35(45):6187-6194. PubMed ID: 28966000
[TBL] [Abstract][Full Text] [Related]
5. Optimization of frequency and targeting of measles supplemental immunization activities in Nigeria: A cost-effectiveness analysis.
Zimmermann M; Frey K; Hagedorn B; Oteri AJ; Yahya A; Hamisu M; Mogekwu F; Shuaib F; McCarthy KA; Chabot-Couture G
Vaccine; 2019 Sep; 37(41):6039-6047. PubMed ID: 31471147
[TBL] [Abstract][Full Text] [Related]
6. An economic evaluation of the current measles vaccination program: A case study in Zhejiang Province, east China.
Zeng Y; Luo M; Chen J; He H; Deng X; Xie S; Fang Y
Vaccine; 2019 May; 37(23):3071-3077. PubMed ID: 31040084
[TBL] [Abstract][Full Text] [Related]
7. A cost-effectiveness analysis of traditional and geographic information system-supported microplanning approaches for routine immunization program management in northern Nigeria.
Ali D; Levin A; Abdulkarim M; Tijjani U; Ahmed B; Namalam F; Oyewole F; Dougherty L
Vaccine; 2020 Feb; 38(6):1408-1415. PubMed ID: 31924428
[TBL] [Abstract][Full Text] [Related]
8. Measles epidemiology and outbreak response immunization in a rural community in Peru.
Sniadack DH; Moscoso B; Aguilar R; Heath J; Bellini W; Chiu MC
Bull World Health Organ; 1999; 77(7):545-52. PubMed ID: 10444877
[TBL] [Abstract][Full Text] [Related]
9. Cost-effectiveness of supplementary immunization for measles in India.
Dabral M
Indian Pediatr; 2009 Nov; 46(11):957-62. PubMed ID: 19578225
[TBL] [Abstract][Full Text] [Related]
10. The average cost of measles cases and adverse events following vaccination in industrialised countries.
Carabin H; Edmunds WJ; Kou U; van den Hof S; Nguyen VH
BMC Public Health; 2002 Sep; 2():22. PubMed ID: 12241559
[TBL] [Abstract][Full Text] [Related]
11. [Economic evaluation on different two-dose-vaccination-strategies related to Measles, Mumps and Rubella Combined Attenuated Live Vaccine].
He HQ; Zhang B; Yan R; Li Q; Fu J; Tang XW; Zhou Y; Deng X; Xie SY
Zhonghua Liu Xing Bing Xue Za Zhi; 2016 Aug; 37(8):1121-6. PubMed ID: 27539345
[TBL] [Abstract][Full Text] [Related]
12. Supplementary immunization activities (SIAs) in South Africa: comprehensive economic evaluation of an integrated child health delivery platform.
Verguet S; Jassat W; Bertram MY; Tollman SM; Murray CJ; Jamison DT; Hofman KJ
Glob Health Action; 2013 Mar; 6():1-9. PubMed ID: 23458088
[TBL] [Abstract][Full Text] [Related]
13. Assessing the cost-effectiveness of measles elimination in Uganda: local impact of a global eradication program.
Babigumira JB; Levin A; Burgess C; Garrison LP; Bauch CT; Braka F; Mbabazi WB; Nabyonga JO; Simons E; Dabbagh A
J Infect Dis; 2011 Jul; 204 Suppl 1():S116-23. PubMed ID: 21666152
[TBL] [Abstract][Full Text] [Related]
14. Cost-effectiveness of a new rotavirus vaccination program in Pakistan: a decision tree model.
Patel HD; Roberts ET; Constenla DO
Vaccine; 2013 Dec; 31(51):6072-8. PubMed ID: 24176497
[TBL] [Abstract][Full Text] [Related]
15. Economic analysis of measles elimination program in the Republic of Korea, 2001: a cost benefit analysis study.
Bae GR; Choe YJ; Go UY; Kim YI; Lee JK
Vaccine; 2013 May; 31(24):2661-6. PubMed ID: 23602654
[TBL] [Abstract][Full Text] [Related]
16. Sustainable Development Goals and childhood measles vaccination in Ekiti State, Nigeria: Results from spatial and interrupted time series analyses.
Ilesanmi MM; Adeyinka DA; Olakunde BO
Vaccine; 2022 Jun; 40(28):3861-3868. PubMed ID: 35644673
[TBL] [Abstract][Full Text] [Related]
17. Impact of measles supplementary immunization activities on reaching children missed by routine programs.
Portnoy A; Jit M; Helleringer S; Verguet S
Vaccine; 2018 Jan; 36(1):170-178. PubMed ID: 29174680
[TBL] [Abstract][Full Text] [Related]
18. Cost-effectiveness of measles treatment: a systematic review.
Vo NX; Van Nguyen AT; Mai Tran HT; Thuy Truong LT; Bao Nguyen NN
J Pak Med Assoc; 2019 Jun; 69(Suppl 2)(6):S148-S154. PubMed ID: 31369545
[TBL] [Abstract][Full Text] [Related]
19. The cost saving opportunity of introducing a card review into measles-containing vaccination campaigns.
Hagedorn BL; Dabbagh A; McCarthy KA
Vaccine; 2019 Sep; 37(41):6093-6101. PubMed ID: 31471145
[TBL] [Abstract][Full Text] [Related]
20. Cost-effectiveness of Strategies for Offering Influenza Vaccine in the Pediatric Emergency Department.
Hart RJ; Stevenson MD; Smith MJ; LaJoie AS; Cross K
JAMA Pediatr; 2018 Jan; 172(1):e173879. PubMed ID: 29114729
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]